Class information for:
Level 1: 5 HT1A RECEPTOR//BUSPIRONE//8 OH DPAT

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
3624 1942 38.8 73%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
11 4 NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL 1112395
76 3       NEUROSCIENCES//DOPAMINE//SEROTONIN 81359
218 2             SEROTONIN//5 HT1A RECEPTOR//5 HT2A RECEPTOR 20633
3624 1                   5 HT1A RECEPTOR//BUSPIRONE//8 OH DPAT 1942

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 5 HT1A RECEPTOR authKW 920432 16% 19% 307
2 BUSPIRONE authKW 768542 9% 28% 172
3 8 OH DPAT authKW 334534 6% 18% 118
4 IPSAPIRONE authKW 315979 3% 36% 56
5 GEPIRONE authKW 283192 2% 51% 35
6 TANDOSPIRONE authKW 233288 2% 46% 32
7 5 HT1A AGONISTS authKW 231008 1% 64% 23
8 FLESINOXAN authKW 224337 2% 42% 34
9 WAY 100635 authKW 162628 3% 18% 56
10 NAN 190 authKW 153460 1% 41% 24

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Pharmacology & Pharmacy 23692 64% 0% 1234
2 Neurosciences 9053 40% 0% 782
3 Psychiatry 4843 19% 0% 363
4 Behavioral Sciences 2994 9% 0% 179
5 Chemistry, Medicinal 325 5% 0% 89
6 Clinical Neurology 223 6% 0% 121
7 Psychology, Clinical 140 2% 0% 46
8 Medicine, Research & Experimental 69 3% 0% 67
9 Psychology, Biological 29 1% 0% 11
10 Psychology 23 1% 0% 24

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 MRC CLIN PHARMACOL UNIT 35373 0% 75% 3
2 PHYSIOL PSYCHOL 1 23568 0% 17% 9
3 BIOCHEM NEUROCHEM 20961 0% 67% 2
4 BIOCHEM NEUROPHARMACOL UNIT 20961 0% 67% 2
5 PHARM PSYCHOPHARMACOL 20961 0% 67% 2
6 156 RUE VAUGIRARD 15722 0% 100% 1
7 91 BLVD HOP 15722 0% 100% 1
8 ASTRA NEUROSCI UNIT 15722 0% 100% 1
9 BEHAB PHARMACOL 15722 0% 100% 1
10 CHEM CSI 15722 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 EUROPEAN JOURNAL OF PHARMACOLOGY 25312 11% 1% 213
2 PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR 16650 6% 1% 115
3 NEUROPHARMACOLOGY 12616 4% 1% 87
4 PSYCHOPHARMACOLOGY 11399 5% 1% 94
5 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 6483 5% 0% 94
6 BEHAVIOURAL PHARMACOLOGY 5864 1% 1% 27
7 JOURNAL OF CLINICAL PSYCHIATRY 3850 2% 1% 42
8 NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 3308 2% 1% 36
9 DRUG DEVELOPMENT RESEARCH 3294 1% 1% 25
10 PSYCHOPHARMACOLOGY BULLETIN 2509 1% 1% 17

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 5 HT1A RECEPTOR 920432 16% 19% 307 Search 5+HT1A+RECEPTOR Search 5+HT1A+RECEPTOR
2 BUSPIRONE 768542 9% 28% 172 Search BUSPIRONE Search BUSPIRONE
3 8 OH DPAT 334534 6% 18% 118 Search 8+OH+DPAT Search 8+OH+DPAT
4 IPSAPIRONE 315979 3% 36% 56 Search IPSAPIRONE Search IPSAPIRONE
5 GEPIRONE 283192 2% 51% 35 Search GEPIRONE Search GEPIRONE
6 TANDOSPIRONE 233288 2% 46% 32 Search TANDOSPIRONE Search TANDOSPIRONE
7 5 HT1A AGONISTS 231008 1% 64% 23 Search 5+HT1A+AGONISTS Search 5+HT1A+AGONISTS
8 FLESINOXAN 224337 2% 42% 34 Search FLESINOXAN Search FLESINOXAN
9 WAY 100635 162628 3% 18% 56 Search WAY+100635 Search WAY+100635
10 NAN 190 153460 1% 41% 24 Search NAN+190 Search NAN+190

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 MULLER, CP , CAREY, RJ , HUSTON, JP , SILVA, MAD , (2007) SEROTONIN AND PSYCHOSTIMULANT ADDICTION: FOCUS ON 5-HT1A-RECEPTORS.PROGRESS IN NEUROBIOLOGY. VOL. 81. ISSUE 3. P. 133-178 163 32% 142
2 DEVRY, J , (1995) 5-HT1A RECEPTOR AGONISTS - RECENT DEVELOPMENTS AND CONTROVERSIAL ISSUES.PSYCHOPHARMACOLOGY. VOL. 121. ISSUE 1. P. 1-26 74 65% 395
3 PECKNOLD, JC , (1994) SEROTONIN 5-HT1A AGONISTS - A COMPARATIVE REVIEW.CNS DRUGS. VOL. 2. ISSUE 3. P. 234-251 80 70% 43
4 ZIFA, E , FILLION, G , (1992) 5-HYDROXYTRYPTAMINE RECEPTORS.PHARMACOLOGICAL REVIEWS. VOL. 44. ISSUE 3. P. 401-458 166 22% 624
5 NEW, JS , (1990) THE DISCOVERY AND DEVELOPMENT OF BUSPIRONE - A NEW APPROACH TO THE TREATMENT OF ANXIETY.MEDICINAL RESEARCH REVIEWS. VOL. 10. ISSUE 3. P. 283-326 81 78% 67
6 HENSLER, JG , (2003) REGULATION OF 5-HT1A RECEPTOR FUNCTION IN BRAIN FOLLOWING AGONIST OR ANTIDEPRESSANT ADMINISTRATION.LIFE SCIENCES. VOL. 72. ISSUE 15. P. 1665-1682 60 56% 131
7 GOA, KL , WARD, A , (1986) BUSPIRONE - A PRELIMINARY REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY AS AN ANXIOLYTIC.DRUGS. VOL. 32. ISSUE 2. P. 114-129 57 92% 300
8 GRIEBEL, G , (1999) 5-HT1A RECEPTOR BLOCKERS AS POTENTIAL DRUG CANDIDATES FOR THE TREATMENT OF ANXIETY DISORDERS.DRUG NEWS & PERSPECTIVES. VOL. 12. ISSUE 8. P. 484 -490 48 77% 30
9 ASTIER, B , SENAS, LL , SOULIERE, F , SCHMITT, P , URBAIN, N , RENTERO, N , BERT, L , DENOROY, L , RENAUD, B , LESOURD, M , ET AL (2003) IN VIVO COMPARISON OF TWO 5-HT1A RECEPTORS AGONISTS ALNESPIRONE (S-20499) AND BUSPIRONE ON LOCUS COERULEUS NEURONAL ACTIVITY.EUROPEAN JOURNAL OF PHARMACOLOGY. VOL. 459. ISSUE 1. P. 17-26 51 64% 7
10 BARRETT, JE , (1992) STUDIES ON THE EFFECTS OF 5-HT(1A) DRUGS IN THE PIGEON.DRUG DEVELOPMENT RESEARCH. VOL. 26. ISSUE 3. P. 299-317 62 74% 17

Classes with closest relation at Level 1


Rank Class id link
1 11921 5 HT1B RECEPTOR//5 HT MODULINE//UNITE PHARMACOL NEUROIMMUNOENDOCRINIENNE
2 7952 PINDOLOL//VILAZODONE//5 HT1A RECEPTOR
3 18005 ARYLPIPERAZINES//5 HT1A LIGANDS//LONG CHAIN ARYLPIPERAZINES
4 20838 SEROTONIN MODULATED ANTICONSOLIDATION PROTEIN//UMR 7521LN2C//3 2 CARBOXYPIPERAZIN 4 YLPROPYL 1 PHOSPHONIC ACID
5 10808 D FENFLURAMINE//FENFLURAMINE//PROLACTIN
6 30621 SEROTONIN1A RECEPTOR//BOVINE HIPPOCAMPUS//P MPPF
7 3578 5 HT2C RECEPTOR//5 HT2A RECEPTOR//5 HT2C
8 20134 URAPIDIL//PHARMACOLOGY URAPIDIL//URAPIDIL HYDROCHLORIDE
9 7472 ELEVATED PLUS MAZE//ONE TRIAL TOLERANCE//PLUS MAZE
10 12327 ARIPIPRAZOLE//BLONANSERIN//CONDITIONED AVOIDANCE RESPONSE

Go to start page